selatogrel
Generic: selatogrel
selatogrel: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Viatris Inc (VTRS) | Phase 1 |
Clinical Trials (1)
An Open-label, Single-dose, Phase 1 Study to Evaluate the Pharmacokinetics of Selatogrel in Subjects With Mild and Moderate Hepatic Impairment Compared to Matched Healthy Subjects
Frequently asked questions
Who is developing selatogrel?
selatogrel is being developed by Viatris Inc.
How many clinical trials involve selatogrel?
BioSniper tracks 1 clinical trial involving selatogrel.
Get deeper analysis on selatogrel
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis